Submission to the Journal

There is no restriction on the length of the papers. Electronic files regarding the full details of the experimental procedure (conference slides, video sequences, software, etc), which can not be published in a normal way, can be deposited as supplementary material.

Authors can distribute an unlimited number of E-reprints via E-mail free of charge. Accepted papers will be published immediately. Authors are kindly asked to prepare and submit manuscripts according the following instructions.

IJPT publishes regular research papers, reviews, mini-reviews and case reports which deal with all aspects of experimental and clinical pharmacology.

Submitted manuscripts must meet the following criteria:

• the material must be original
• the writing must be clear, concise and unambiguous
• the data are valid
• the conclusions drawn by the authors must be reasonable and supportable
• the information must be relevant and interesting.

When electronically submitting a manuscript for publication consideration, designate a corresponding author and provide a complete mailing address, telephone and fax numbers, and an E-mail address (homepage address is optional) for person himself. The corresponding author will be identified as such in the published article and an email address will be identified for this individual. Email addresses must also be provided for all authors identified on a manuscript.

Contributors should prepare their manuscripts in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Submit the manuscript as an E-mail attachment file (preferably in MS Word (any version) format).

Use Système International (SI) measurements only, except when dual report is indicated in the SI unit conversion table in these instructions. Use non-proprietary (i.e. generic) drug names, unless the specific trade name of a drug is directly relevant to the discussion. Avoid unnecessary abbreviations.

Double-space the text throughout. This includes the title page, abstract, text, acknowledgments, references, tables and figure legends. Use Times New Romans and a 12-point font size.

On the title page include the full names and affiliations of all authors. Authors' full address, homepage address, phone and fax numbers and e-mail address can be included in the title page and these will be published. In addition to full title, a short title not more than 60 characters is appreciated.

Include a structured abstract of no more than 250 words. A list of three to five keywords must be given, and placed after the Abstract.

For experimental investigations of human or animal subjects, state in the Methods section of the manuscript that an appropriate institutional review board approved the project. Provide the approval numbers as necessary. For investigations of human subjects, state in the Methods section the manner in which informed consent was obtained.

Number the references in the order that they appear in the text of the manuscript. When listing references, follow the uniform requirements style (the Vancouver style) that is based largely on an ANSI standard style adapted by the NLM for its databases (e.g., MEDLINE). Reference numbers should be placed in square brackets [ ] throughout the text, and placed before the punctuation; for example [4] or [1-3], and all the references should be listed separately and as the last section at the end of the manuscript.

Authors are encouraged to prepare figures and schemes in color. Full color graphics will be published free of charge. Conference slides, video sequences, software, etc., can be included and published as supplementary material.

Tables should be inserted into the main text, and numbers and titles for all tables supplied. All table columns should have an explanatory heading.

All tables and figures should be numbered in the order of their citation in the text. Include legends for all figures, schemes and tables. The legends should be prepared as a separate paragraph of the main text and placed in the main text before a table and after a figure or a scheme.